The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: BIA

Monday Biotech Deal Review: March 29, 2010

This week’s Canadian biotech deals include an acquisition by Biovail, Hæmacure’s BIA filing comes to a predictable end, MethylGene finds $8.9 million in its couch cushions from some Ontario numbered corps, Leap Medical leaps ahead with $1 million from MSBiV and other Quebec favourites, and BioSyntech borrows against its SR&EDs.  Those, plus more securities, debt [...]

If You License IP in Canada, You Need to Know About Recent BIA/CCAA Amendments

Adapted from a bulletin by my colleagues Evan Cobb and Brad Newman: In the U.S., Section 365(n) of the bankruptcy code provides protection to licensees in the event their licensor becomes insolvent.  Canadian law has not historically had that protection, forcing licensors to set up dedicated IP holding companies or other bankruptcy-remote structures to protect [...]

Follow

Get every new post delivered to your Inbox.

Join 92 other followers